$FRX Recent Headlines U.S. stocks end choppy t
Post# of 44974
Posted On: 05/20/2014 9:44:44 AM
$FRX Recent Headlines
U.S. stocks end choppy trade higher 5:07 p.m. April 28, 2014 - Anora Mahmudova
Plug Power tanks on fuel-cell criticism; Pfizer gains 3:47 p.m. April 28, 2014 - Sue Chang
Health-care market rises on Merger Monday deals 11:52 a.m. April 28, 2014 - Russ Britt
Stock futures point to rise as drug stocks rally 9:29 a.m. April 28, 2014 - Anora Mahmudova
Forest Labs buys Furiex for $1.1 bln in cash 7:35 a.m. April 28, 2014 - Saumya Vaishampayan
Furiex surges 36% after acquisition by Forest 7:25 a.m. April 28, 2014 - Saumya Vaishampayan
Forest Labs buys Furiex for $1.1 bln in cash 7:24 a.m. April 28, 2014 - Saumya Vaishampayan
Richter, Forest bipolar-drug trial result positive 3:24 a.m. March 31, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
Forest Laboratories gains 2.7% to lead the S&P 500 9:31 a.m. March 24, 2014 - Sue Chang
Icahn Enterprises reports profit up 144% in 2013 11:23 a.m. March 3, 2014 - MarketWatch
Stocks rally; S&P 500 ends right below record 5:46 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 6:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Smart Money sells into Mylan rise for a good reason 3:05 p.m. Feb. 20, 2014 - The Trading Deck
Actavis continues hot streak with better-than-expected earnings 12:21 p.m. Feb. 20, 2014 - Russ Britt
Actavis swings to loss on charges, write-downs 9:04 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 2:59 p.m. Feb. 19, 2014 - Russ Britt
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 12:03 p.m. Feb. 19, 2014 - Russ Britt
U.S. stocks edge up; Nasdaq gains for 8th day in a row 5:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 5:11 p.m. Feb. 18, 2014 - Sue Chang
Tracking Carl Icahn's Portfolio - Q1 2014 Update 1:46 a.m. Today - Seeking Alpha
Will This Price Target Increase Help Forest Laboratory (FRX) Stock Today? 9:18 a.m. May 19, 2014 - TheStreet.com
A Proud 'Dinosaur' of Stock Picking 11:44 a.m. May 16, 2014 - The Wall Street Journal Interactive Edition
J.P.Morgan's Geoff Meacham Plucks Biotechs With Upside From A Down Market 9:17 a.m. May 16, 2014 - Seeking Alpha
GuruFocus Guru of the 2013 Carl Icahn's Top First Quarter Holdings 6:34 p.m. May 15, 2014 - GuruFocus.com
Synergy Pharma Posts Narrower-than-Expected Q1 Loss - Analyst Blog 11:00 a.m. May 14, 2014 - Zacks.com
New leadership team at Actavis after Forest deal closes 9:56 a.m. May 14, 2014 - Seeking Alpha
Forest Labs' Saunders to Head Actavis When Deal Closes 8:55 a.m. May 14, 2014 - The Wall Street Journal Interactive Edition
Several meds may help break the alcohol habit 7:22 a.m. May 14, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – CAH PDLI SHPG FRX 2:00 p.m. May 13, 2014 - InvestorPlace.com
Cross-Border Megamergers Drive Global Takeover Boom 4:01 p.m. May 12, 2014 - Investors Business Daily
Antibiotics Approvals to Surge 7:06 a.m. May 12, 2014 - Barrons.com
M.D. Sass: Bullish on Broadcast, Health Care 3:26 a.m. May 10, 2014 - Barrons.com
International Guru Bernard Horn Reports His Top Five in the First Quarter 6:38 p.m. May 7, 2014 - GuruFocus.com
Mario Gabelli's GAMCO Investors Top 5 New Stocks 4:24 p.m. May 7, 2014 - GuruFocus.com
3 Stocks Pushing The Health Care Sector Lower 1:03 p.m. May 7, 2014 - TheStreet.com
Forest Laboratories Inc (FRX): Today's Featured Drugs Laggard 5:01 p.m. May 6, 2014 - TheStreet.com
Commit To Buy Forest Laboratories At $87.50, Earn 8.3% Annualized Using Options 11:36 a.m. May 5, 2014 - TheStreet.com
Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. May 2, 2014 - TheStreet.com
A Look At World Stocks' Q1: Shire, Actavis, NXP Semi 4:32 p.m. May 1, 2014 - Investors Business Daily
Forest Laboratories, Inc. to Present Data about Aclidinium, Aclidinium/Formoterol Combination, and Roflumilast at the American Thoracic Society International Conference 4:05 p.m. May 16, 2014 - BusinessWire - BZX
Forest Laboratories, Inc. to Present Nebivolol/Valsartan Fixed-Dose Combination Data at the American Society of Hypertension Annual Scientific Meeting 4:05 p.m. May 16, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection With the Sale of Furiex Pharmaceuticals, Inc. to Forest Laboratories, Inc. and Royal Empress, Inc. -- FURX 7:11 p.m. May 14, 2014 - GlobeNewswire
Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Forest Laboratories Acquisition 8:00 a.m. May 14, 2014 - PR Newswire - PRF
RiverVest Venture Partners’ Portfolio Company Lumena is Sold to Shire for $260 million; Represents Sixth Exit from RiverVest Venture Fund II 10:39 a.m. May 12, 2014 - BusinessWire - BZX
Pharma Stocks Technical Briefing -- Research on Forest Laboratories, Valeant Pharma, IntelliPharmaCeutics Intl., and Acura Pharma 8:09 a.m. May 8, 2014 - PR Newswire - PRF
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 6:32 p.m. May 7, 2014 - PR Newswire - PRF
Genetic Disorders Partnering Terms and Agreements 5:35 p.m. May 7, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT:Brower Piven Announces the Investigation of Furiex Pharmaceuticals, Inc. in Connection with the Proposed Sale of the Company to Forest Laboratories, Inc. 4:41 p.m. May 5, 2014 - BusinessWire - BZX
Former Forest Laboratories GC Joins Lowenstein Sandler's Life Sciences Practice 10:00 a.m. May 5, 2014 - PR Newswire - PRF
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:02 a.m. May 5, 2014 - BusinessWire - BZX
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:00 a.m. May 5, 2014 - PR Newswire - PRF
Earnings Results, Acquisitions, Drug Designations, Dividend Authorizations, and Licensing Agreements - Analyst Notes on AstraZeneca, Furiex, GW, Techne and Agenus 8:00 a.m. May 5, 2014 - PR Newswire - PRF
Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene 8:00 a.m. May 5, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Furiex Pharmaceuticals, Inc. Buyout 3:37 p.m. May 1, 2014 - BusinessWire - BZX
Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2014 8:31 a.m. May 1, 2014 - BusinessWire - BZX
Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline and Drop Tax Rate, an Industrial Info News Alert 6:31 a.m. April 30, 2014 - Marketwire
Ryan & Maniskas, LLP Announces Investigation of Furiex Pharmaceuticals, Inc. 10:35 a.m. April 29, 2014 - PR Newswire - PRF
FURIEX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Furiex Pharmaceuticals, Inc. (FURX) Over the Proposed Sale of the Company to Forest Laboratories, Inc. 8:25 p.m. April 28, 2014 - BusinessWire - BZX
Acquisition of Furiex Pharmaceuticals, Inc. by Forest Laboratories, Inc. May Not Be in Shareholders' Best Interests 6:57 p.m. April 28, 2014 - PR Newswire - PRF
U.S. stocks end choppy trade higher 5:07 p.m. April 28, 2014 - Anora Mahmudova
Plug Power tanks on fuel-cell criticism; Pfizer gains 3:47 p.m. April 28, 2014 - Sue Chang
Health-care market rises on Merger Monday deals 11:52 a.m. April 28, 2014 - Russ Britt
Stock futures point to rise as drug stocks rally 9:29 a.m. April 28, 2014 - Anora Mahmudova
Forest Labs buys Furiex for $1.1 bln in cash 7:35 a.m. April 28, 2014 - Saumya Vaishampayan
Furiex surges 36% after acquisition by Forest 7:25 a.m. April 28, 2014 - Saumya Vaishampayan
Forest Labs buys Furiex for $1.1 bln in cash 7:24 a.m. April 28, 2014 - Saumya Vaishampayan
Richter, Forest bipolar-drug trial result positive 3:24 a.m. March 31, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
Forest Laboratories gains 2.7% to lead the S&P 500 9:31 a.m. March 24, 2014 - Sue Chang
Icahn Enterprises reports profit up 144% in 2013 11:23 a.m. March 3, 2014 - MarketWatch
Stocks rally; S&P 500 ends right below record 5:46 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 6:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Smart Money sells into Mylan rise for a good reason 3:05 p.m. Feb. 20, 2014 - The Trading Deck
Actavis continues hot streak with better-than-expected earnings 12:21 p.m. Feb. 20, 2014 - Russ Britt
Actavis swings to loss on charges, write-downs 9:04 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 2:59 p.m. Feb. 19, 2014 - Russ Britt
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 12:03 p.m. Feb. 19, 2014 - Russ Britt
U.S. stocks edge up; Nasdaq gains for 8th day in a row 5:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 5:11 p.m. Feb. 18, 2014 - Sue Chang
Tracking Carl Icahn's Portfolio - Q1 2014 Update 1:46 a.m. Today - Seeking Alpha
Will This Price Target Increase Help Forest Laboratory (FRX) Stock Today? 9:18 a.m. May 19, 2014 - TheStreet.com
A Proud 'Dinosaur' of Stock Picking 11:44 a.m. May 16, 2014 - The Wall Street Journal Interactive Edition
J.P.Morgan's Geoff Meacham Plucks Biotechs With Upside From A Down Market 9:17 a.m. May 16, 2014 - Seeking Alpha
GuruFocus Guru of the 2013 Carl Icahn's Top First Quarter Holdings 6:34 p.m. May 15, 2014 - GuruFocus.com
Synergy Pharma Posts Narrower-than-Expected Q1 Loss - Analyst Blog 11:00 a.m. May 14, 2014 - Zacks.com
New leadership team at Actavis after Forest deal closes 9:56 a.m. May 14, 2014 - Seeking Alpha
Forest Labs' Saunders to Head Actavis When Deal Closes 8:55 a.m. May 14, 2014 - The Wall Street Journal Interactive Edition
Several meds may help break the alcohol habit 7:22 a.m. May 14, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – CAH PDLI SHPG FRX 2:00 p.m. May 13, 2014 - InvestorPlace.com
Cross-Border Megamergers Drive Global Takeover Boom 4:01 p.m. May 12, 2014 - Investors Business Daily
Antibiotics Approvals to Surge 7:06 a.m. May 12, 2014 - Barrons.com
M.D. Sass: Bullish on Broadcast, Health Care 3:26 a.m. May 10, 2014 - Barrons.com
International Guru Bernard Horn Reports His Top Five in the First Quarter 6:38 p.m. May 7, 2014 - GuruFocus.com
Mario Gabelli's GAMCO Investors Top 5 New Stocks 4:24 p.m. May 7, 2014 - GuruFocus.com
3 Stocks Pushing The Health Care Sector Lower 1:03 p.m. May 7, 2014 - TheStreet.com
Forest Laboratories Inc (FRX): Today's Featured Drugs Laggard 5:01 p.m. May 6, 2014 - TheStreet.com
Commit To Buy Forest Laboratories At $87.50, Earn 8.3% Annualized Using Options 11:36 a.m. May 5, 2014 - TheStreet.com
Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. May 2, 2014 - TheStreet.com
A Look At World Stocks' Q1: Shire, Actavis, NXP Semi 4:32 p.m. May 1, 2014 - Investors Business Daily
Forest Laboratories, Inc. to Present Data about Aclidinium, Aclidinium/Formoterol Combination, and Roflumilast at the American Thoracic Society International Conference 4:05 p.m. May 16, 2014 - BusinessWire - BZX
Forest Laboratories, Inc. to Present Nebivolol/Valsartan Fixed-Dose Combination Data at the American Society of Hypertension Annual Scientific Meeting 4:05 p.m. May 16, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection With the Sale of Furiex Pharmaceuticals, Inc. to Forest Laboratories, Inc. and Royal Empress, Inc. -- FURX 7:11 p.m. May 14, 2014 - GlobeNewswire
Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Forest Laboratories Acquisition 8:00 a.m. May 14, 2014 - PR Newswire - PRF
RiverVest Venture Partners’ Portfolio Company Lumena is Sold to Shire for $260 million; Represents Sixth Exit from RiverVest Venture Fund II 10:39 a.m. May 12, 2014 - BusinessWire - BZX
Pharma Stocks Technical Briefing -- Research on Forest Laboratories, Valeant Pharma, IntelliPharmaCeutics Intl., and Acura Pharma 8:09 a.m. May 8, 2014 - PR Newswire - PRF
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 6:32 p.m. May 7, 2014 - PR Newswire - PRF
Genetic Disorders Partnering Terms and Agreements 5:35 p.m. May 7, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT:Brower Piven Announces the Investigation of Furiex Pharmaceuticals, Inc. in Connection with the Proposed Sale of the Company to Forest Laboratories, Inc. 4:41 p.m. May 5, 2014 - BusinessWire - BZX
Former Forest Laboratories GC Joins Lowenstein Sandler's Life Sciences Practice 10:00 a.m. May 5, 2014 - PR Newswire - PRF
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:02 a.m. May 5, 2014 - BusinessWire - BZX
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:00 a.m. May 5, 2014 - PR Newswire - PRF
Earnings Results, Acquisitions, Drug Designations, Dividend Authorizations, and Licensing Agreements - Analyst Notes on AstraZeneca, Furiex, GW, Techne and Agenus 8:00 a.m. May 5, 2014 - PR Newswire - PRF
Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene 8:00 a.m. May 5, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Furiex Pharmaceuticals, Inc. Buyout 3:37 p.m. May 1, 2014 - BusinessWire - BZX
Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2014 8:31 a.m. May 1, 2014 - BusinessWire - BZX
Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline and Drop Tax Rate, an Industrial Info News Alert 6:31 a.m. April 30, 2014 - Marketwire
Ryan & Maniskas, LLP Announces Investigation of Furiex Pharmaceuticals, Inc. 10:35 a.m. April 29, 2014 - PR Newswire - PRF
FURIEX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Furiex Pharmaceuticals, Inc. (FURX) Over the Proposed Sale of the Company to Forest Laboratories, Inc. 8:25 p.m. April 28, 2014 - BusinessWire - BZX
Acquisition of Furiex Pharmaceuticals, Inc. by Forest Laboratories, Inc. May Not Be in Shareholders' Best Interests 6:57 p.m. April 28, 2014 - PR Newswire - PRF
(0)
(0)